Waldemar F.
- Country
- Poland
- Department
- #40677: Oddzial Neurologiczny
Research Overview
- Phase III Randomized Double‑Blind Study of Fenebrutinib versus Teriflunomide for Efficacy and Safety in Adults with Relapsing Multiple Sclerosis
- Phase 3 Randomized Trial of Human Normal Immunoglobulin to Prevent Infections in IgG‑deficient Patients with Autoimmune/Rheumatic Disease on B‑cell Depletion Therapy
- Phase 3 Randomized Double-Blind Study of Orelabrutinib for Primary Progressive Multiple Sclerosis in Patients With PPMS
Data & Insights
Has run more than one trial at 313 of 608 partner sites.
Specializations
Multiple Sclerosis Research
This investigator specializes in various forms of multiple sclerosis, including relapsing multiple sclerosis (RMS) and primary progressive multiple sclerosis (PPMS). Their research encompasses innovative therapeutic approaches for managing MS progression and symptoms.
- Relapsing Forms Treatment
- Progressive Disease Management
- Long-term Disease Monitoring
Epilepsy Studies
The investigator conducts extensive research in refractory focal onset epilepsy and primary generalized tonic-clonic seizures. Their work includes evaluation of novel therapeutic approaches for seizure management.
- Focal Onset Seizures
- Drug-resistant Epilepsy
- Seizure Prevention Strategies
Neurological Conditions
Additional areas of focus include chronic inflammatory demyelinating polyneuropathy (CIDP) and stroke prevention. The investigator studies innovative treatments for various neurological disorders.
- Inflammatory Neuropathies
- Post-stroke Care
- Neurological Disease Management
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.